{
  "SimulationMappings": [
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_2mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_2mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_2mgkg_Kd_fit"
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_5mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_5mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_5mgkg_Kd_fit"
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_10mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_10mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_10mgkg_Kd_fit"
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_20mgkg_Kd_fit",
      "Path": "Tefibazumab/Tefibazumab_20mgkg_Kd_fit/",
      "SimulationFile": "Tefibazumab_20mgkg_Kd_fit"
    }
  ],
  "ObservedDataMappings": [
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose10",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose10.csv"
    },
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose2",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose2.csv"
    },
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose20",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose20.csv"
    },
    {
      "Id": "Reilley2005_tefibazumab_PKSimImport.Dose5",
      "Path": "ObservedData/Reilley2005_tefibazumab_PKSimImport.Dose5.csv"
    }
  ],
  "Plots": [
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_2mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 2 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 2 mg/kg dose (linear scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_2mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Log",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_2mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 2 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose2|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose2|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 2 mg/kg dose (log scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#00FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_2mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_5mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 5 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 5 mg/kg dose (linear scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_5mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Log",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_5mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 5 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose5|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose5|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 5 mg/kg dose (log scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#00FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_5mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_10mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 10 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 10 mg/kg dose (linear scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_10mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Log",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_10mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 10 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose10|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose10|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 10 mg/kg dose (log scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#00FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_10mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_20mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 20 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 20 mg/kg dose (linear scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_fit\n2023-03-07 10:08"
      }
    },
    {
      "Project": "Tefibazumab",
      "Simulation": "Tefibazumab_20mgkg_Kd_fit",
      "SectionReference": "ct-profiles",
      "Plot": {
        "$type": "PKSim.Core.Snapshots.CurveChart, PKSim.Core",
        "Axes": [
          {
            "Unit": "day(s)",
            "Dimension": "Time",
            "Type": "X",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "None",
            "Scaling": "Linear",
            "NumberMode": "Normal"
          },
          {
            "Unit": "µmol/l",
            "Dimension": "Concentration (molar)",
            "Type": "Y",
            "GridLines": false,
            "Visible": true,
            "DefaultColor": "#FFFFFF",
            "DefaultLineStyle": "Solid",
            "Scaling": "Log",
            "NumberMode": "Normal"
          }
        ],
        "Curves": [
          {
            "Name": "Tefibazumab-Peripheral Venous Blood-Plasma-Concentration",
            "X": "Time",
            "Y": "Tefibazumab_20mgkg_Kd_fit|Organism|PeripheralVenousBlood|Tefibazumab|Plasma (Peripheral Venous Blood)",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 1
            }
          },
          {
            "Name": "Reilley2005_tefibazumab_Dose 20 mg/kg",
            "X": "Reilley2005_tefibazumab_PKSimImport.Dose20|Time",
            "Y": "Reilley2005_tefibazumab_PKSimImport.Dose20|ObservedData|Peripheral Venous Blood|Plasma|Tefibazumab|Measurement",
            "CurveOptions": {
              "Color": "#FF0000",
              "LegendIndex": 2,
              "LineStyle": "None",
              "Symbol": "Circle"
            }
          }
        ],
        "Name": "Plasma concentration - 20 mg/kg dose (log scale)",
        "FontAndSize": {
          "Fonts": {
            "AxisSize": 10,
            "LegendSize": 8,
            "TitleSize": 16,
            "DescriptionSize": 12,
            "OriginSize": 8,
            "FontFamilyName": "Microsoft Sans Serif",
            "WatermarkSize": 32
          }
        },
        "Settings": {
          "SideMarginsEnabled": true,
          "LegendPosition": "RightInside",
          "BackColor": "#00FFFFFF",
          "DiagramBackColor": "#FFFFFF"
        },
        "OriginText": "Tefibazumab\nTefibazumab_20mgkg_Kd_fit\n2023-03-07 10:08"
      }
    }
  ],
  "Inputs": [
    {
      "SectionReference": "final-input-parameters",
      "Path": "Inputs/Tefibazumab/Compound/Tefibazumab.md"
    }
  ]
}